Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Post-thrombotic Syndrome Prevention
NCT04833764Phase 2Unknown
- Start
- Jun 2021
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in post-thrombotic syndrome (PTS). Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
post-thrombotic syndrome (PTS)
Beyond the preview
Go deeper on NCT04833764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833764.